24 results
8-K
EX-99.1
jbx8fbyqz4rhas1hr82n
12 May 22
ENDRA Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update
4:06pm
8-K
EX-1.1
cs20m rry
21 Jun 21
Entry into a Material Definitive Agreement
4:58pm
8-K
EX-99.1
d9dla81jk4wl4 tu
17 May 21
ENDRA Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update
4:05pm
8-K
EX-99.1
zekofrjyvyic iyg
25 Mar 21
ENDRA Life Sciences Reports 2020 Fourth Quarter and Full Year Financial Results, Provides Business Update
12:00am
8-K
EX-1.1
2yhzy2esc
19 Feb 21
Entry into a Material Definitive Agreement
4:13pm
8-K
EX-1.1
jcujjk
18 Dec 20
ENDRA Life Sciences Announces Proposed Public Offering of Common Stock
5:04pm
8-K
EX-1.1
38s wzdz201x5dl0add
25 Sep 20
Entry into a Material Definitive Agreement
4:54pm
8-K
EX-99.1
ndmklohd0d
13 Apr 20
ENDRA Life Sciences Announces Cash Strategy and Business Update in Response to COVID-19
4:29pm
8-K
EX-10.1
3obtp njl
26 Dec 19
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
p4u5h7ygvqog
11 Dec 19
ENDRA Life Sciences Completes $8.1 Million Private Placement
5:14pm
8-K
EX-10.1
odpryaew8gq2hxq8h
29 Jul 19
ENDRA Life Sciences Completes Private Placement of $2.8 Million of Convertible Secured Notes and Warrants
8:40am